Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Juno Just Raised A Ton of Cash. Here Comes the Spending Part. 12/19/14 Seattle
With $2B Market Cap and New Shareholder Rules, Juno Ready for Debut 12/18/14 Seattle
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
Connecture Prices Well Below Projection in Nasdaq Debut 12/12/14 Wisconsin
Lending Club Shares Soar 56 Percent In Market Debut 12/11/14 San Francisco
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
TX Roundup: Need, Experiment Engine, Bigcommerce, Bellicum, CS Disco 12/02/14 Texas
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
Déjà Vu for Agios as Second Drug Shines in Small Blood Cancer Study 11/18/14 Boston
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
Sage’s Drug For Rare Epilepsy Shows Promise in Small Study 11/10/14 Boston
West Coast Biotech Roundup: Nevro, Coherus, Xenon, Rock Health, Etc. 11/06/14 San Francisco
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
Bio Venture Specialists Advent Raise $235M For European, U.S. Deals 10/28/14 National
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
Organovo CEO: Closing IPO Window Could Spur More Reverse Mergers 10/24/14 Wisconsin
Proteon Cuts Price, Boosts Shares to Bag $61M in IPO 10/22/14 Boston
As Atlas Splits, Is There A Case To Make In Venture For Specialists? 10/22/14 National
Connecture, WI Health Insurance Software Company, Plans $86M IPO 10/21/14 Wisconsin
With Invesco’s Support, PureTech Boosts Power to Back Startups 10/20/14 Boston
Colorado’s Zayo Worth $5B Following $400M IPO 10/17/14 Boulder/Denver
Atara Bio Pays the Price for Delayed IPO, Sinks in Debut 10/16/14 San Francisco
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
Page 1 of 13 next page »